2024 annual financial data
NewAmsterdam Pharma 2024 Net margin
Direct answer
Net margin was -530.25%.
Operating income was -176,289,000 USD and net income was -241,598,000 USD.
Operating cash flow was -158,564,000 USD.
Get free NewAmsterdam Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 45,563,000 USD
- Operating income
- -176,289,000 USD
- Net income
- -241,598,000 USD
- Operating cash flow
- -158,564,000 USD